Login

HERNAN CHIESSA - Head of Press and Communications at Metrogas, discusses warnings on the use of... Federico Barni, CEO of Bumeran, participates. 00:10:00

Share On Facebook Share On Twitter

Tomas Cordoba - CEO - MetroGAS

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Women Are Natural Problem Solvers|Susan Lyne,Managing Partner and Co-Founder,BBG Ventures
00:10:00
Nordea's Resilience and Strong Performance in 2023 | Frank Vang-Jensen, CEO, Nordea .
00:10:00
Marika Lulay, CEO of GFT, delivers her speech at the Annual General Meeting.
00:10:00
Spotlight on Jennifer Johnson: Impact Investing Leader
00:10:00
Innovators and commercial leaders in dermatology|Matt Callahan,Executive Director,Botanix Pharmaceuticals Ltd
00:10:00
Understanding Market Headlines: What They Really Mean for You | Jennifer Luzzatto, President, Summit Financial Partners, Inc.
00:10:00
Megatrends: Forecasting AI’s Impact on Our Jobs with Vanguard’s Joe Davis, Ph.D.
00:10:00
Targeting the Lost Generation: Bridging the Age Gap in Broadcasting | Karl Thedéen , CEO of Edgeware AB
00:10:00
Watch our new free webinar to learn about Qualified Electronic Registered Delivery Services (SERCQ) and whether they can replace PEC, explained by Sabrina Dondi, Head of Competence Center at Doxee.|Sergio Muratori Casali is Founder & Co-CEO of Doxee SpA
00:10:00
Promoting Green Energy: Opportunities for the Philippines| Francis Giles B Puno, CEO, First Gen Corp.
00:10:00
Evaluating the Competitive Threat of Fintechs to Emerging Market Banks: Insights from T. Rowe Price
00:10:00
The Impact of Emotions and Cognitive Biases on Investment Decisions

© 2026 Nehu